Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

Biogen is investing $2 billion in its U.S. manufacturing footprint — but not in Massachusetts, where the drug company is ...

In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy ...

AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing ...

Operations have begun at an Abu Dhabi vaccine distribution hub primed to deliver millions of doses each year as part of a mission to improve access to health care across the region. The logistics ...

Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 3.8% in the afternoon session after TD Cowen lowered ...

Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 3.4% in the morning session as investors ...

"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...

David Cory is an industry veteran, bringing more than 30 years of operational experience, in private and public, emerging-stage biotech and large pharma companies with an established track record of ...